About Us | Contact

Christopher G Azzoli Investigator

Medical Oncology Rhode Island Hospital NPI1861463895
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$45,713.22
from 38 payments in the last 6 years

Total Cash or Cash Equivalent

$37,137.98
from 22 payments in the last 6 years

Total In-kind Items & Services

$8,575.24
from 16 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
10/06/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1400.00 Details
Payment from JAZZ PHARMACEUTICALS INC.
Payment Record ID 845634031
10/18/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3180.00 Details
Payment from JAZZ PHARMACEUTICALS INC.
Payment Record ID 845631789
12/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2064.00 Details
Payment from GENZYME CORPORATION
Payment Record ID 843401875
10/19/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2226.25 Details
Payment from Daiichi Sankyo Inc.
Payment Record ID 836325605
11/05/2020 General (Non-Research) Cash or cash equivalent Honoraria $1000.00 Details
Payment from Pfizer Inc.
Payment Record ID 832709193
11/24/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3425.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 830189909
11/01/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1370.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 830042533
12/28/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2397.50 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 829989067
06/28/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $500.00 Details
Payment from Novocure Inc.
Payment Record ID 823635673
03/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1500.00 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Payment Record ID 819856505
03/20/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1500.00 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Payment Record ID 819856503
07/09/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2292.50 Details
Payment from Regeneron Healthcare Solutions, Inc.
Payment Record ID 809556807
10/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1625.00 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 783559791
11/03/2019 General (Non-Research) Cash or cash equivalent Food and Beverage $65.91 Details
Payment from Foundation Medicine, Inc.
Payment Record ID 675547321
10/17/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $3000.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504808357
10/17/2017 General (Non-Research) Cash or cash equivalent Travel and Lodging $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504808351
09/07/2017 General (Non-Research) In-kind items and services Food and Beverage $58.17 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504773733
09/06/2017 General (Non-Research) In-kind items and services Travel and Lodging $5064.33 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504773729
09/07/2017 General (Non-Research) In-kind items and services Travel and Lodging $484.70 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504773727
09/07/2017 General (Non-Research) In-kind items and services Travel and Lodging $409.58 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504773723
09/06/2017 General (Non-Research) In-kind items and services Travel and Lodging $135.72 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504773307
09/07/2017 General (Non-Research) In-kind items and services Food and Beverage $10.30 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504773303
03/08/2017 General (Non-Research) In-kind items and services Food and Beverage $39.53 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504060479
03/08/2017 General (Non-Research) In-kind items and services Food and Beverage $39.53 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504006581
03/07/2017 General (Non-Research) In-kind items and services Travel and Lodging $326.57 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504006315
03/08/2017 General (Non-Research) In-kind items and services Food and Beverage $29.52 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504006313
03/07/2017 General (Non-Research) In-kind items and services Travel and Lodging $919.20 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504003519
03/08/2017 General (Non-Research) In-kind items and services Travel and Lodging $64.13 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 504003517
04/21/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $6500.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503882823
04/21/2017 General (Non-Research) Cash or cash equivalent Travel and Lodging $150.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503882819
03/16/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $1625.00 Details
Payment from ARIAD Pharmaceuticals, Inc.
Payment Record ID 464299017
06/23/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $537.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 446433606
06/04/2017 General (Non-Research) Cash or cash equivalent Food and Beverage $92.82 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 446232407
06/26/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $537.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 445119725
10/27/2016 General (Non-Research) In-kind items and services Travel and Lodging $153.90 Details
Payment from Genentech, Inc.
Payment Record ID 402903284
10/27/2016 General (Non-Research) In-kind items and services Travel and Lodging $343.54 Details
Payment from Genentech, Inc.
Payment Record ID 402902614
10/28/2016 General (Non-Research) In-kind items and services Food and Beverage $189.77 Details
Payment from Genentech, Inc.
Payment Record ID 402900712
08/25/2016 Research In-kind items and services $306.75 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BARICITINIB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Clinical Trials Gov ID NCT02576938
Payment Record ID 372518520
;